Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Mar;29(2):e109-e110.
doi: 10.1097/IPC.0000000000000971. Epub 2020 Nov 9.

Disseminated Herpes Zoster During COVID-19

Olivier Voisin  1 , Nina Deluca  1 , Annabelle Mahé  1 , Erwan Lelorc'h  1 , Sidonie Hubert  1 , Elodie Ménage  1 , Marie-Françoise Borie  1 , Philippe Azria  1 , Charlotte Fite  2 , Benoit Pilmis  3 , Jean-Jacques Mourad  1
Affiliations
Case Reports

Disseminated Herpes Zoster During COVID-19

Olivier Voisin et al. Infect Dis Clin Pract (Baltim Md). 2021 Mar.

Abstract

During the SARS-CoV-2 pandemic, a variety of dermatological conditions were reported by physicians. Given the context, these lesions have been labeled as secondary to SARS-CoV-2 infection. We report the case of a recurrence of herpes zoster in a patient hospitalized with an SARS-CoV-2 infection. The rash occurred on the 15th day of hospitalization while the patient was recovering from a severe form. Local swab showed the presence of varicella-zoster virus within the vesicles. Dermatological symptoms secondary to COVID-19 have been frequently described. This is the first case that demonstrates the recurrence of herpes zoster during a SARS-CoV-2 infection.

Keywords: COVID-19; SARS-CoV-2; VZV; chickenpox; herpes zoster; varicella-zoster virus.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding or conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Vesicular lesions of different age and topography.
See this image and copyright information in PMC

References

    1. Marzano AV Genovese G Fabbrocini G, et al. . Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients. J Am Acad Dermatol. 2020;83(1):280–285. - PMC - PubMed
    1. Garg S Wynne K Omoyinmi E, et al. . Efficacy and safety of anakinra for undifferentiated autoinflammatory diseases in children: a retrospective case review. Rheumatol Adv Pract. 2019;3(1):rkz004. - PMC - PubMed
    1. Lequerré T Quartier P Rosellini D, et al. . Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset still disease: preliminary experience in France. Ann Rheum Dis. 2008;67(3):302–308. - PubMed
    1. Rigante D Ansuini V Berrettini A, et al. . Exposition to chickenpox of two children with autoinflammatory syndromes under treatment with anakinra. Rheumatol Int. 2008;28(8):793–796. - PubMed
    1. Mourgues C Henquell C Tatar Z, et al. . Surveillance de la charge virale des virus Epstein-Barr (EBV), cytomégalovirus (CMV) et de la varicelle (VZV) chez les patients traités par tocilizumab pour la polyarthrite rhumatoïde. Joint Bone Spine. 2016;83(4):412–415. - PubMed

Publication types